A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer
新型 EGFR 抑制剂 HNPMI 通过调节结肠癌细胞中的 BCL-2/BAX 和 p53 来调节细胞凋亡和肿瘤发生
期刊:British Journal of Pharmacology
影响因子:6.8
doi:10.1111/bph.16141
Jeyalakshmi Kandhavelu, Kumar Subramanian, Vivash Naidoo, Giulia Sebastianelli, Phuong Doan, Saravanan Konda Mani, Hande Yapislar, Ebru Haciosmanoglu, Leman Arslan, Samed Ozer, Ramesh Thiyagarajan, Nuno R Candeias, Clement Penny, Meenakshisundaram Kandhavelu, Akshaya Murugesan
信号转导
细胞生物学
肿瘤
肠癌
肿瘤细胞
FCM
IF
IHC-P
Apoptosis
BCL2
